News Chart Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME Other stock markets 11:35:12 2024-05-08 am EDT			5-day change	1st Jan Change
1.97 ^EUR	+0.92%		+0.51%	+4.34%

May. 06	Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat	CI

41d16e3dbaccfea.Dhem6GE0Ca2BnH-NJ9CM2ODOplYibSBIABizRbtlAio.TEffvj58Pcje8xnoSbz6jZCr8DlsJBAGalz9GoIvb1NlZu-cOXB79NHJOg~816a2985e261672d712e85c010fc297c